A new Keck Medicine of USC study published in Leukemia Research suggests that a bone marrow transplant from a haploidentical (half-identical) relative may greatly increase patients’ odds of success, in addition to being easier to find.

Patients who received their transplant from a half-identical relative were about 70% more likely to avoid relapse than those who received a bone marrow transplant from a fully identical relative.

Parents and children are guaranteed half-matches, while siblings have a 50% chance of being half-matches.

To read the full story, click here.